Evidence map›Paper›PMID 41432407›Full record

ArticleMicrobiology spectrum2026

Improved detection of group B

Natalia Silva Costa, Andre Rio-Tinto, Julia de Deus Santana, Julia Ferrarezi Favorato Moriel Garcia, Isabella Bittencourt Ferreira Pinto, Laylla Graca Barros, Ana Clarisse Merces, Eduardo Oliveira Bressan, Laura Maria Andrade Oliveira, Sergio Eduardo Longo Fracalanzza and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Natalia Silva CostaInstituto de Microbiologia Paulo de Goes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.ORCID 0000-0002-9194-6445
Andre Rio-TintoInstituto de Microbiologia Paulo de Goes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.ORCID 0000-0003-1718-438X
Julia de Deus SantanaInstituto de Microbiologia Paulo de Goes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Julia Ferrarezi Favorato Moriel GarciaInstituto de Microbiologia Paulo de Goes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Isabella Bittencourt Ferreira PintoInstituto de Microbiologia Paulo de Goes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Laylla Graca BarrosInstituto de Microbiologia Paulo de Goes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Ana Clarisse MercesInstituto de Microbiologia Paulo de Goes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Eduardo Oliveira BressanInstituto de Microbiologia Paulo de Goes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Laura Maria Andrade OliveiraInstituto de Microbiologia Paulo de Goes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Sergio Eduardo Longo FracalanzzaInstituto de Microbiologia Paulo de Goes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Lucia Martins TeixeiraInstituto de Microbiologia Paulo de Goes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.ORCID 0000-0002-4017-7076
Penélope Saldanha MarinhoMaternidade Escola, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Tatiana Castro Abreu PintoInstituto de Microbiologia Paulo de Goes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

Funding

Conselho Nacional de Desenvolvimento Científico e TecnológicoCoordenação de Aperfeiçoamento de Pessoal de Nível SuperiorFundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/210.071/2024
6 · The paper itself

Abstract

Universal screening of pregnant individuals followed by intrapartum antibiotic prophylaxis is the most effective approach to prevent group B

Indexed as

Bacteriological TechniquesChromogenic CompoundsCulture MediaPregnancy Complications, InfectiousRectumStreptococcal InfectionsStreptococcus agalactiaeVaginaAdultBrazilFemaleHumansMass ScreeningPregnancySensitivity and SpecificityChromogenic CompoundsCulture Mediachromogenic mediagroup B Streptococcuspregnant individuals

Identifiers

PMID41432407
PMCPMC12889057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.